Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children

por Shiragami, Makoto, Mizukami, Akiko, Leeuwenkamp, Oscar, Mrkvan, Tomas, Delgleize, Emmanuelle, Kurono, Yuichi, Iwata, Satoshi
Publicado 2014

Reply to Farkouh RA et al. Comment on “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pne...

por Shiragami, Makoto, Mizukami, Akiko, Leeuwenkamp, Oscar, Mrkvan, Tomas, Delgleize, Emmanuelle, Kurono, Yuichi, Iwata, Satoshi
Publicado 2015

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany

por Curran, Desmond, Van Oorschot, Desirée, Varghese, Lijoy, Oostvogels, Lidia, Mrkvan, Tomas, Colindres, Romulo, von Krempelhuber, Alfred, Anastassopoulou, Anastassia
Publicado 2017

In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression

por Webster, Kylie E., Walters, Stacey, Kohler, Rachel E., Mrkvan, Tomas, Boyman, Onur, Surh, Charles D., Grey, Shane T., Sprent, Jonathan
Publicado 2009

Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging

por Del Giudice, Giuseppe, Goronzy, Jörg J., Grubeck-Loebenstein, Beatrix, Lambert, Paul-Henri, Mrkvan, Tomas, Stoddard, Jeffrey J., Doherty, T. Mark
Publicado 2017

Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck

por Boucek, Jan, Mrkvan, Tomas, Chovanec, Martin, Kuchar, Martin, Betka, Jaroslav, Boucek, Vladimir, Hladikova, Marie, Betka, Jan, Eckschlager, Tomas, Rihova, Blanka
Publicado 2010

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-...

por Mrkvan, Tomas, Campora, Laura, Catteau, Grégory, Douha, Martine, Grupping, Katrijn, Herve, Caroline, Kalema, George, Heineman, Thomas, Klein, Nicola P, Lal, Himal, Oostvogels, Lidia, Schuind, Anne
Publicado 2018

2905. Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling

por Bastidas, Adriana, Catteau, Grégory, Volpe, Stéphanie, Mrkvan, Tomas, Enemuo, Adaora, Smetana, Jan, Schwarz, Tino, Rombo, Lars, Pauksens, Karlis, Berengier, Estelle, Hervé, Caroline, Oostvogels, Lidia, Schuind, Anne
Publicado 2019

Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination

por Hastie, Andrew, Catteau, Grégory, Enemuo, Adaora, Mrkvan, Tomas, Salaun, Bruno, Volpe, Stephanie, Smetana, Jan, Rombo, Lars, Schwarz, Tino, Pauksens, Karlis, Hervé, Caroline, Bastidas, Adriana, Schuind, Anne
Publicado 2020

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

por Oostvogels, Lidia, Heineman, Thomas C., Johnson, Robert W., Levin, Myron J., McElhaney, Janet E., Van den Steen, Peter, Zahaf, Toufik, Dagnew, Alemnew F., Chlibek, Roman, Diez-Domingo, Javier, Gorfinkel, Iris S., Hervé, Caroline, Hwang, Shinn-Jang, Ikematsu, Hideyuki, Kalema, George, Lal, Himal, McNeil, Shelly A., Mrkvan, Tomas, Pauksens, Karlis, Smetana, Jan, Watanabe, Daisuke, Weckx, Lily Yin, Cunningham, Anthony L.
Publicado 2019